Cardiff Oncology, Inc.·4

Sep 20, 6:08 PM ET

White Lale 4

4 · Cardiff Oncology, Inc. · Filed Sep 20, 2022

Insider Transaction Report

Form 4
Period: 2022-09-19
White Lale
Director
Transactions
  • Purchase

    Common Stock

    2022-09-19$1.64/sh+15,000$24,525113,788 total(indirect: By Trust)
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.625 to $1.64. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.

Documents

1 file
  • 4
    wf-form4_166371172268717.xmlPrimary

    FORM 4